Evidence map›Paper›PMID 34174904›Full record

ArticleAIDS research and therapy2021

Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study.

Emma O'Halloran Leach, Huiyin Lu, Joshua Caballero, Jennifer E Thomas, Emma C Spencer, Robert L Cook

Open access · goldAbstract read
In one paragraph

Article in AIDS research and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Emma O'Halloran LeachSHARC Center for Translational HIV Research, University of Florida, 2004 Mowry Road, Gainesville, 32610, USA. emmaleach@ufl.edu.ORCID 0000-0001-7610-0874
Huiyin LuSCHARP, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Joshua CaballeroDepartment of Clinical and Administrative Sciences, College of Pharmacy, Larkin University, 18301 North Miami Avenue, Miami, FL, 33169, USA.
Jennifer E ThomasDepartment of Clinical and Administrative Sciences, College of Pharmacy, Larkin University, 18301 North Miami Avenue, Miami, FL, 33169, USA.
Emma C SpencerDivision of Disease Control and Health Protection, Florida Department of Health, 4052 Bald Cypress Way, Tallahassee, FL, BIN A0932399-1715, USA.
Robert L CookSHARC Center for Translational HIV Research, University of Florida, 2004 Mowry Road, Gainesville, 32610, USA.
Larkin University · USUniversity of Florida · USFlorida Department of Health · USFred Hutch Cancer Center · US

Funding

Southern HIV and Alcohol Research Consortium Administrative and Research Support CoreU24AA022002 · NIAAA · UNIVERSITY OF FLORIDA · PI COOK, ROBERT L · 2012 to 2022
$5.5M
Administrative Supplement Role of Gut Microbial Dysbiosis in Aging on HIV-associated in the Development of Alzheimer's DiseaseAssociated Dementia (ADRD).U01AA026225 · NIAAA · UNIVERSITY OF LOUISVILLE · PI BARVE, SHIRISH S, COOK, ROBERT L · 2017 to 2021
$3.4M
NIAAA NIH HHS U01 AA026225NIAAA NIH HHS U24 AA022002
6 · The paper itself

Abstract

backgroundWhen considering adherence to antiretroviral therapy (ART) for HIV, many different cut-points are used. The primary goals of this study were to identify a level of self-reported medication adherence that best distinguished HIV viral suppression from non-suppression, and to compare the ability of a single-item and a 3-item adherence questionnaire to predict HIV viral suppression.

methodsThis cross-sectional analysis included 380 persons with HIV (PWH) from the Florida Cohort study who completed a self-reported ART adherence measure within 30-days of having an HIV viral load test. We used Receiver Operating Characteristic (ROC) curve analyses and ROCContrast to compare the ability of a single-item and a 3-item self-reported adherence measure to predict HIV viral suppression (defined as ≤ 200 copies/mL). We used the Youden index and chi square statistics to assess specific cut-points, and repeated the analysis with a different definition of HIV viral suppression (≤ 1000 copies/mL).

resultsThe mean percent adherence was 92.4% using the single-item score and 90.4% using the 3-item score; 81.6% had viral suppression. The areas under the curve for the single-item and 3-item adherence measures were generally poor overall and not significantly different from each other (0.589 and 0.580, p = 0.67). The Youden index identified cut-points of 93% and 89% as maximizing the sensitivity and specificity for the single-item and 3-item measures, respectively, whereas a cut-point of 80% on the single-item measure was best able to discriminate those with viral suppression (58% vs. 84%, p < 0.001). Results were similar with viral suppression defined as ≤ 1000 copies/mL.

conclusionsIn this sample of PWH, a single question on medication adherence was as good as a 3-item questionnaire in predicting HIV viral suppression, although neither had good discriminatory ability. A cut-point close to 90% adherence maximized sensitivity and specificity, although viral suppression was very similar for nearly all measures above 80%.

Indexed as

Anti-HIV AgentsHIV InfectionsCohort StudiesCross-Sectional StudiesHumansMedication AdherenceSelf ReportViral LoadAnti-HIV AgentsAdherenceARTHIVSelf-reportedViral suppression

Identifiers

PMID34174904
PMCPMC8234726
OpenAlexW3175179808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.